Published in Cancer Weekly, November 25th, 2003
The achievement promises to enhance the ability of physicians to more accurately diagnose ALL, improve their ability to accurately monitor a patient's response to therapy, and eventually, develop more effective and less toxic drugs to treat this cancer.
The findings will also provide an invaluable resource for exploring the biological events that turn normal white blood cells into leukemic cells, according to James Downing, MD, chair of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.